Annual Information Update

RNS Number : 8619C

Intl. Biotechnology Trust PLC

20 November 2009

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the "Company")

Annual information update

As required by Prospectus Rule 5.2, all information which has been made available to the public by the Company over the previous 12 months in the United Kingdom (being the Company's Home State) which is required to be disclosed pursuant to this Rule is outlined below. In order to avoid an unnecessarily lengthy document, information is referred to in this update rather than included in full.

The information referred to in this update was up to date at the time the information was published but some information may now be out of date. 

Announcements made via RNS, a Regulatory Information Service

The following UK regulatory announcements were published on the London Stock Exchange via RNS, a Regulatory Information Service on the dates indicated.

Date of publication	Headline	Brief description of announcement
19 November 2009	Transaction in Own Shares	The Company announces that it has bought back 660,000 Ordinary shares for 120p each to be held in Treasury.
19 November 2009	Portfolio Update	The Company releases its monthly factsheet as at 31 October 2009.
19 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
18 November 2009	Cancellation of Treasury Shares	The Company announces that it has cancelled from Treasury 655,000 Ordinary shares.
18 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
17 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
17 November 2009	Portfolio Update	The Company announces a follow on investment in the portfolio company Affinium Pharmaceuticals Inc.
16 November 2009	Portfolio Update	The Company announces a follow on investment in the portfolio company Entellus Medical Inc.
16 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
13 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
13 November 2009	Cancellation of Treasury Shares	The Company announces that it has cancelled from Treasury 750,000 Ordinary shares.
12 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
12 November 2009	Cancellation of Treasury Shares	The Company announces that it has cancelled from Treasury 750,000 Ordinary shares.
11 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
10 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 November 2009	Portfolio Update	The Company announces a further investment in the unquoted portfolio company Allocure.
6 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
5 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
5 November 2009	Portfolio Update	The Company announces a further investment in the unquoted portfolio company Delenex Therapeutics.
4 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
3 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 November 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 November 2009	Cancellation of Treasury Shares	The Company announces that it has cancelled from Treasury 1,250,000 Ordinary shares.
2 November 2009	Portfolio Update	The Company announces a further investment in the unquoted portfolio company Ricerca.
30 October 2009	Total Voting Rights	The Company announce its total voting rights as at 30 October 2009.
30 October 2009	Annual Report	The Company announces that 2 copies of the Annual Report have been lodged with the UK Listing Authority.
30 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
30 October 2009	Cancellation of Treasury Shares	The Company announces that it has cancelled from Treasury 750,000 Ordinary shares.
29 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
28 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
27 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
26 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
26 October 2009	Portfolio Update	The Company announces that the Directors' valuation of the holdings in the portfolio companies Itero Pharmaceuticals, Oxagen and Ricerca had been changed which resulted in a net impact on the NAV of an increase of £35k or 0.05 pence per share.
23 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
23 October 2009	Annual Financial Report	The Company releases its Annual Financial Report announcement for the year ended 31 August 2009.
22 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
21 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
20 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
19 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
19 October 2009	Portfolio Update	The Company announces a follow on investment in the unquoted portfolio company Lux Biosciences.
16 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
15 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
14 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
13 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
12 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 October 2009	Holding(s) in Company	The Company announces that Reed Elsevier Pension Trustee Limited holds 1,961,906 Ordinary 25p shares in the Company.
9 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 October 2009	Portfolio Update	The Company releases its monthly factsheet as at 30 September 2009.
8 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
7 October 2009	Portfolio Update	The Company announces a follow on investment in the unquoted portfolio company TransEnterix.
7 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
6 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
5 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
1 October 2009	Net Asset Value(s)	Ordinary share net asset value statement.
30 September 2009	Portfolio Update	The Company announces that the Directors' valuation of the holdings in the portfolio company Lux Biosciences and a portfolio company which cannot be named have decreased from £1.08m to £0.97m and from £1.07m to £0.94m respectively.
30 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
29 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
28 September 2009	Portfolio Update	The Company announces that the Directors' valuation of the holding in unquoted portfolio company Entellus has decreased from £0.9m to £0.8m.
28 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
25 September 2009	Holding(s) in Company	The Company announces that Ballie Gifford & Co hold 3,247,333 Ordinary 25p shares in the Company.
25 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
24 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
23 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
22 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
21 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
18 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
18 September 2009	Portfolio Update	The Company releases it's monthly factsheet as at 31 August 2009.
17 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
16 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
15 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
14 September 2009	Portfolio Update	The Company announces that the Directors' valuation of the holding in unquoted portfolio company ESBATech has been increased from £1.3m to £2.1m.
14 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
11 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
10 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
8 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
7 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
4 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
3 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
1 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
1 September 2009	Net Asset Value(s)	Ordinary share net asset value statement.
28 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
28 August 2009	Portfolio Update	The Company announces that the Directors' valuation of the holding in unquoted portfolio company Archemix has decreased from £1.0m to £0.8m.
27 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
27 August 2009	Portfolio Update	The Company announces that an unquoted portfolio company is close to concluding a sale of its business to an acquirer.
26 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
26 August 2009	Portfolio Update	The Company announces that the Directors' valuation of the holding in an unquoted portfolio company has decreased from £2.8m to £2.3m.
25 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
24 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
21 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
20 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
19 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
18 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
18 August 2009	Holding(s) in Company	The Company announces that AXA S.A and its group of companies holds 3,219,041 shares in the Company.
17 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
14 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
13 August 2009	Portfolio Update	The Company releases it's monthly factsheet as at 31 July 2009.
13 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
12 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
11 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
10 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
7 August 2009	Directorate Change	The Company announces the appointment of Dr Veronique Bouchet as a Director of the Company with effect from 1 September 2009.
7 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
6 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
5 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
4 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
3 August 2009	Net Asset Value(s)	Ordinary share net asset value statement.
3 August 2009	Portfolio Update	The Company announces a follow on investment in the unquoted portfolio company Cadent Holdings.
31 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
30 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
29 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
28 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
27 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
24 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
23 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
22 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
21 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
20 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
17 July 2009	Portfolio Update	The Company announces a change of the Directors' valuation of the holding in Ricerca Biosciences from £0.6m to £0.4m.
17 July 2009	Portfolio Update	The Company releases it's monthly factsheet as at 30 June 2009.
17 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
16 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
15 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
14 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
13 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
10 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 July 2009	Interim Management Statement	The Company releases its Interim Management Statement for the three months ended 31 May 2009.
9 July 2009	Blocklisting Interim Review	The Company releases its blocklisting interim review for the period 10 January 2009 to 9 July 2009.
8 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
7 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
6 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
3 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 July 2009	Portfolio Update	The Company announcements that the Directors' valuation of the holding in Itero Pharmaceuticals has been decreased from £0.6m($1.0m) to £0.3m ($0.5m).
1 July 2009	Net Asset Value(s)	Ordinary share net asset value statement.
30 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
29 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
26 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
25 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
25 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
23 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
22 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
19 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
18 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
17 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
17 June 2009	Portfolio Update	The Company announces that the Directors' valuation of the holding in an unquoted portfolio company has decreased from £4.1m to £2.7m.
16 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
15 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
12 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
11 June 2009	Portfolio Update	The Company releases its monthly factsheet as at 31 May 2009.
11 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
11 June 2009	Portfolio Update	Further to the announcement made on 6 May 2009, the Company announces that the Letter of Intent received by one of the Company's unquoted portfolio companies had been withdrawn and a new round of externally priced funding was being raised.
10 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 June 2009	Portfolio Update	The Company announces that the share price of Micromet, Inc. has increased from $4.61 to $4.97 and therefore represented 7.9% of the Company's net asset value from 7.3%.
9 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
8 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
5 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
4 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
3 June 2009	Portfolio Update	The Company announces a follow on investment in the unquoted portfolio company Lux Biosciences.
3 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
1 June 2009	Portfolio Update	The Company announces a follow on investment in the unquoted portfolio company RespiVert.
1 June 2009	Net Asset Value(s)	Ordinary share net asset value statement.
29 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
28 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
27 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
26 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
22 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
21 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
20 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
19 May 2009	Portfolio Update	The Company releases it's monthly factsheet as at 30 April 2009.
19 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
18 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
15 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
14 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
13 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
12 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
11 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
11 May 2009	Portfolio Update	The Company announces that the portfolio company VNUS Medical Technologies had signed an agreement to be acquired.
8 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
7 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
6 May 2009	Portfolio Update	The Company announces a change of the Directors valuation from £1.0m to £1.1m in an unquoted portfolio company which had received a signed Letter of Intent.
6 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
5 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
1 May 2009	Net Asset Value(s)	Ordinary share net asset value statement.
1 May 2009	Document re. Half Yearly Report	The Company announces that 2 copies of the Half Yearly Report have been lodged with the UK Listing Authority.
30 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
29 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
28 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
27 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
24 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
24 April 2009	Portfolio Update	The Company announces that a reduction in the valuation of unquoted portfolio company Ricerca Biosciences has resulted in a drop in the Company's net asset value of 0.4p per share.
23 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
22 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
21 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
20 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
20 April 2009	Half Yearly Report	The Company releases its Half Yearly Report announcement for the six months ended 28 February 2009.
17 April 2009	Portfolio Update	The Company announces it's monthly factsheet as at 31 March 2009.
17 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
16 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
15 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
14 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
8 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
7 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
6 April 2009	Portfolio Update	The Company announces a follow on investment in the unquoted portfolio company ESBATech.
6 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
3 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
1 April 2009	Net Asset Value(s)	Ordinary share net asset value statement.
31 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
30 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
27 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
26 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
25 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
24 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
23 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
20 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
19 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
18 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
17 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
16 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
13 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
12 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
11 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
10 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
6 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
5 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
4 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
4 March 2009	Portfolio Update	The Company announces its top ten holdings as at 27 February 2009.
3 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 March 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 March 2009	Company Secretary Change	The Company announces that BNP Paribas Secretarial Services Limited has been appointed as Company Secretary with effect from 1 March 2009.
27 February 2009	Total Voting Rights	The Company announces its total voting rights as at 27 February 2009.
27 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
26 February 2009	Transaction in Own Shares	The Company announces that it has bought back 620,000 Ordinary shares to be held in treasury.
26 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
25 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
24 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
23 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
20 February 2009	Transaction in Own Shares	The Company announces that it has bought back 60,000 Ordinary shares to be held in treasury.
20 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
19 February 2009	Portfolio Update	The Company announces a follow on investment in the unquoted portfolio company TransEnterix.
19 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
18 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
17 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
16 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
13 February 2009	Transaction in Own Shares	The Company announces that it has bought back 90,000 Ordinary shares to be held in treasury.
13 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
12 February 2009	Transaction in Own Shares	The Company announces that it has bought back 75,000 Ordinary shares to be held in treasury.
12 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
11 February 2009	Transaction in Own Shares	The Company announces that it has bought back 75,000 Ordinary shares to be held in treasury.
11 February 2009	Portfolio Update	The Company announces that the Directors' valuation of the holding in unquoted portfolio company Cadent has increased from £1,647,000 to £2,140,000.
11 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
10 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 February 2009	Transaction in Own Shares	The Company announces that it has bought back 50,000 Ordinary shares to be held in treasury.
9 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
6 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
6 February 2009	Portfolio Update	The Company announces changes to the Directors' valuations of unquoted portfolio companies Affibody, Dynogen, Ricerca and Intranasal with effect from 5 February 2009.
5 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
4 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
3 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 February 2009	Net Asset Value(s)	Ordinary share net asset value statement.
30 January 2009	Total Voting Rights	The Company announces its total voting rights as at 30 January 2009.
30 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
29 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
28 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
27 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
27 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
26 January 2009	Interim Management Statement	The Company releases its Interim Management Statement for the period ended 30 November 2008.
23 January 2009	Purchase of Shares for Holding in Treasury	The Company announces that it has bought back 35,000 Ordinary shares to be held in treasury.
23 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
22 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
21 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
20 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
19 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
16 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
15 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
14 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
13 January 2009	Transaction in Own Shares	The Company announces that it has bought back 500,000 Ordinary shares to be held in Treasury.
13 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
12 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
9 January 2009	Transaction in Own Shares	The Company announces that it has bought back 100,000 Ordinary shares to be held in Treasury.
9 January 2009	Blocklisting Interim Review	The Company announces its Blocklisting Interim Review for the period 10 July 2008 to 9 January 2009.
9 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
8 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
7 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
6 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
5 January 2009	Net Asset Value(s)	Ordinary share net asset value statement.
2 January 2009	Annual Information Update	Annual Information Update

Copies of the documents published via RNS can be obtained from the Company Secretary at the Company's Registered Office at 55 Moorgate, London EC2R 6PA, or from the London Stock Exchange website, www.londonstockexchange.com.

 Documents filed at Companies House

All of the documents listed below were filed with Companies House at Crown Way, Cardiff CF14 3UZ on or around the dates indicated:

Date of filing	Brief description of document(s) filed
20 November 2009	SH05 - Cancellation of 2,000,000 Ordinary Shares from Treasury.
17 November 2009	CH01 - Change of Service Address filed for all Directors.
20 October 2009	AD03 - Register of Members held at SAIL address.
20 October 2009	AD02 - SAIL address created.
11 September 2009	288a - Véronique Bouchet appointed as a Director with effect from 1 September 2009.
25 March 2009	169(1B) - Notification of shares held in treasury.
25 March 2009	169(1B) - Notification of shares held in treasury.
25 March 2009	169(1B) - Notification of shares held in treasury.
25 March 2009	169(1B) - Notification of shares held in treasury.
25 March 2009	169(1B) - Notification of shares held in treasury.
25 March 2009	169(1B) - Notification of shares held in treasury.
25 March 2009	169(1B) - Notification of shares held in treasury.
19 March 2009	288b - Termination of appointment of Company Secretary.
19 March 2009	288a - Appointment of new Company Secretary.
19 March 2009	287 - Change of Registered Office address.
5 March 2009	363a - Annual Return made up to 31 January 2009.
5 February 2009	Annual Report and Financial Statements for the year ended 31 August 2008.
29 January 2009	Amended Articles of Association.

Copies of the documents filed at Companies House can be obtained from Companies House or from the Company Secretary at the Company's Registered Office, 55 Moorgate, London EC2R 6PA.

Documents sent to shareholders and filed with the UKLA Document Viewing Facility

Date of filing	Brief description of document(s) filed
30 October 2009	*Annual Report and Financial Statements for the year ended 31 August 2009.
9 July 2009	Interim Management Statement for the three months ended 31 May 2009.
1 May 2009	*Half Yearly Report for the year ended for the six months ended 28 February 2009.

* Only these documents were sent to Shareholders.

Documents filed with the UKLA can be obtained from the Document Viewing Facility, Financial Services Authority, the North Colonnade, Canary Wharf, London E14 5HS.

For further information, please contact:

Rachael Nelson

For BNP Paribas Secretarial Services Limited

Company Secretary

Tel: [phone]

20 NOVEMBER 2009

 

END

 

 

AIUXBLFLKFBZFBV